American Journal of Respiratory and Critical Care Medicine · 1998 · 103 citations · 14 references
MedicineHematologyPathologyHematologic OncologyHematopathologyPulmonologyDiffuse Lung DiseaseEdemaPleural DiseaseRetinoic Acid SignalingAcute LeukemiasAcute Promyelocytic LeukemiaAlveolar-capillary Barrier InjuryClinical RemissionDiffuse Pulmonary HemorrhageInterstitital Lung DiseaseLeukemia PathologyLung Biopsy Diagnosis
All-trans-retinoic acid (ATRA) can induce a clinical remission in patients with acute promyelocytic leukemia. An adverse condition called "retinoic acid syndrome" limits this therapy. It is characterized by fever and respiratory distress, along with weight gain, pleural or pericardial effusions, peripheral edema, thromboembolic events, and intermittent hypotension. The lung disease has been previously ascribed to an infiltration of leukemic or maturing myeloid cells into lung parenchyma, which is sometimes associated with pleural effusions and diffuse alveolar hemorrhage. We report a case of retinoic acid syndrome in an 18-yr-old woman who developed diffuse alveolar hemorrhage while being treated with ATRA for acute promyelocytic leukemia. An open lung biopsy revealed pulmonary capillaritis.
14
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Meng‐Er Huang, YC Ye, S R Chen et al. · Blood · 1988 · 2.4K citations · Full text
Medicine, Hematology, Oncology +7
Raymond P. Warrell · New England Journal of Medicine · 1993 · 795 citations
Medicine, Hematology, Pharmacology +16
The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia
Stanley R. Frankel, Gregory Y. Lauwers, Mark A. Weiss et al. · Annals of Internal Medicine · 1992 · 716 citations · Full text
Medicine, Hematology, Oncology +11